Shariah compliance overview
Not HalalStoke Therapeutics, Inc. (STOK) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc. is an emerging biopharmaceutical company dedicated to developing innovative antisense oligonucleotide (ASO) therapies. Its primary focus is to target and address the fundamental causes of severe genetic disorders, particularly within the United States.
Stoke Therapeutics, Inc. (STOK) operates in the Healthcare sector, in the Biotechnology industry.
Why it is not classified as halal: it does not pass these screens: Business Activity.
- Business Activity
- 6.95%Limit 5%Fail
- Interest-bearing debt
- 0.00%Limit 30%Pass
- Interest-bearing securities and assets
- 25.83%Limit 30%Pass
- Dividend purification
- 6.95%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Stoke Therapeutics, Inc. (STOK). Current Akinda screening label: Not Halal.
